Correction: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study (JMIR Formative Research (2022) 6:12 (e37144) DOI: 10.2196/37144)

Jelena Maksimenko (Coresponding Author), Pedro Pereira Rodrigues, Miki Nakazawa-Miklaševiča, David Pinto, Edvins Miklaševičs, Genadijs Trofimovičs, Jānis Gardovskis, Fatima Cardoso, Maria João Cardoso

Research output: Contribution to journalComment/debate

Abstract

In “Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study” (JMIR Form Res 2022;6(12):e37144) the authors noted one error. In the originally published article Figure 6 appeared as a duplicate of Figure 5. Figure 6 has been corrected as follows: (Figure Presented) The correction version appeared in the online version of the paper on the JMIR Publications website on January 18, 2023. Because this was made after submission to full-text repositories, the corrected article has also been resubmitted to those repositories.

Original languageEnglish
Article numbere45810
Pages (from-to)e45810
Number of pages2
JournalJMIR Formative Research
Volume7
DOIs
Publication statusPublished - 16 Mar 2023

Keywords*

  • medicine
  • cancer

Field of Science*

  • 3.1 Basic medicine
  • 3.2 Clinical medicine

Publication Type*

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Correction: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study: Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study (JMIR Formative Research (2022) 6:12 (e37144) DOI: 10.2196/37144)'. Together they form a unique fingerprint.

Cite this